Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease – RPTH
RPTH Journal shared on LinkedIn about a recent article by Mosaad Almegren et al, adding:
”What’s the best anticoagulant for venous thrombosis in sickle cell disease?
Patients with sickle cell disease (SCD) face a high risk of venous thromboembolism, yet evidence guiding anticoagulation choice remains limited.
A new RPTH study compared direct oral anticoagulants (DOACs) vs warfarin in adults with SCD experiencing their first VTE.
Here’s the key signal:
- Similar rates of recurrent thrombosis and major bleeding between DOACs and warfarin.
- Clinically relevant non-major bleeding was significantly lower with DOACs.
Some context from the cohort:
- 99 patients with SCD and VTE
- Pulmonary embolism was the most common event (~65%)
- Median follow-up ~44 months
- Most DOAC use involved rivaroxaban or apixaban
Translation:
For patients with SCD and thrombosis, DOACs may offer comparable protection with less bleeding burden.
Big questions for the field:
- Should DOACs become first-line therapy for VTE in SCD?
- How long should anticoagulation continue in this high-recurrence population?
- Do SCD-specific thrombosis mechanisms require tailored anticoagulation strategies?”
Title: Management of venous thrombosis in sickle cell disease: a comparative study on the use of direct oral anticoagulants and warfarin
Authors: Mosaad Almegren, Eysa N. AlSolamy, Rayan A. Qutob, Mohammed M. Alasmari, Ali Aljeraiwi, Noura Aljuwaisri, Turki Abdulaziz Alshuaibi, Faisal Bahammam, Bader Al Rawahi, Hoor Hamed Al Farsi
Read the Full Article on RPTH
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care